Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Fatty Liver 2Diabetes Mellitus 2Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasms 1Menstruation Disturbances 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Iron Overload 1Hypertriglyceridemia 1Hyperthyroidism 1Hemoglobinopathies 1Graves Disease 1Glucose Metabolism Disorders 1Glucose Intolerance 1Fibrous Dysplasia, Polyostotic 1Fibrous Dysplasia of Bone 1

Interventions

Metformin 3drospirenone and ethinyl estradiol combination 2Caloric Restriction 2cinnulin PF 1Yoga 1Ultrasonography 1Sugars 1Robotic Surgical Procedures 1Population Groups 1Inositol 1Hysterectomy 1Hematologic Tests 1Glucose Tolerance Test 1Folic Acid 1Ethinyl Estradiol 1Doxycycline 1Diet 1Cyproterone acetate, ethinyl estradiol drug combination 1Control Groups 1Contraceptives, Oral 1Acupuncture Therapy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Menstruation Disturbances × Glucose Tolerance Test × Clear all
NCT00283816 2015-05-15

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

University of Rochester

Phase 3 Completed
36 enrolled 9 charts

Menstruation Disturbances, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡